Erik Christensen

Erik Christensen

Auto-generated profile, based on publicly available information

Erik Christensen

Institute of Clinical Biochemistry, University of Oslo, Rikshospitalet, Norway

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 1988 in Acta Psychiatrica Scandinavica
Verified
Journal Article
Closed access
PDF file
OCO. Christensen
O. Christensen
ECE. Christensen
E. Christensen

1 January 1991 in Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism
Verified
Journal Article
Closed access
MGMorten Grønn
Morten Grønn
ECErik Christensen
Erik Christensen
THTor-Arne Hagve
Tor-Arne Hagve
BCBjørn O. Christophersen
Bjørn O. Christophersen

1 April 1992 in Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism
Verified
Journal Article
Closed access
MGMorten Grønn
Morten Grønn
ECErik Christensen
Erik Christensen
THTor Arne Hagve
Tor Arne Hagve
BCBjørn O. Christophersen
Bjørn O. Christophersen

1 January 1993 in Scandinavian Journal of Clinical and Laboratory Investigation
Verified
Journal Article
Closed access
PDF file
ECE. Christensen
E. Christensen
BWB. Woldseth
B. Woldseth
THT.-A. Hagve
T.-A. Hagve
BPB. T. Poll-The
B. T. Poll-The
RWR. J. A. Wanders
R. J. A. Wanders
BCB. O. Christophersen
B. O. Christophersen
The metabolism of the C22 unsaturated fatty acids erucic acid (22:1(n-9)), adrenic acid (22:4(n-6)), docosapentaenoic acid (22:5(n-3)) and docosahexaenoic acid (22:6(n-3)) was studied in cultured fibroblasts from patients with acyl-CoA oxidase deficiency, the Zellweger syndrome, X-linked adrenoleukodystrophy (X-ALD) and normal controls. [3-14C] 22:4 (n-6) and [3-14C] 22:5 (n-3) were shortened (retroconverted) to [1-I4C] 20:4 (n-6) and [1-14C] 20:5 (n-3), respectively, in normal and X-ALD fibroblasts. In Zellweger and acyl-CoA oxidase deficient fibroblasts these reactions were deficient. Since the retroconversion is normal in X-ALD fibroblasts peroxisomal very long chain (lignoceryl) CoA ligase is probably not required for the activation of C22 unsaturated fatty acids. The present work with fibroblasts from patients with a specific acyl-CoA oxidase deficiency, previously shown to have a deficient peroxisomal clofibrate-inducible acyl-CoA oxidase, and which accumulate 24:0 and 26:0 fatty acids, supports the view that this enzyme is responsible for the chain-shortening of docosahexaenoic acid (22:6(n-3)), erucic acid (22:l(n-9)), docosapentaenoic acid (22:5(n-3)), and adrenic acid (22:4(n-6)) as well.

31 July 1989 in Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism
Verified
Journal Article
Closed access
ECErik Christensen
Erik Christensen
THTor-Arne Hagve
Tor-Arne Hagve
MGMorten Grønn
Morten Grønn
BCBjørn O. Christophersen
Bjørn O. Christophersen

1 December 1986 in Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism
Verified
Journal Article
Closed access
ECErik Christensen
Erik Christensen
THTor-Arne Hagve
Tor-Arne Hagve
BCBjørn O. Christophersen
Bjørn O. Christophersen